Supporting the innovators of today for the patient benefit of tomorrow

Aignostics started in 2018 within the walls of Charité Berlin and the Berlin Institute of Health, based on years of research conducted by the pathology department of Charité, TU Berlin and Fraunhofer HHI. Following initial incubation, it spun-out of Charité and BIH in 2020, and is now focusing on pioneering computational pathology for pharmaceutical research, clinical trials and CDx development.

Genome Biologics are leaders in therapeutic target and drug discovery in cardiovascular and cardiometabolic disease. Their technology platforms seamlessly integrate synergistically to accelerate development of therapies to treat illnesses where no other treatments have proven effective or ever existed.

inContAlert is a MedTech start-up developing a wearable to measure the filling level of the urinary bladder. With their sensor technology, body data is captured and analyzed with AI algorithms. The results are visualized within an app and warn patients in time about critical filling levels.

O11 biomedical GmbH is a spin-off from the Institute for Applied Medical Engineering, Dept. of Biohybrids & Medical Textiles (BioTex) at RWTH Aachen University | Aachen University Hospital. Their team consists of highly dedicated biologists, physicians and engineers, and is dedicated to developing a treatment for hypercapnia.

Dimericon is a private biotech company focused on exploring crosslinked helix dimers (Dimericons) as therapeutics and templates for small molecule development. Dimericon’s technology targets hard-to-drug intracellular protein-protein interactions using rationally designed mimetics of helix dimers.The Seed round of financing will support preclinical studies to further develop the current lead compound to be an IND ready clinical candidate in hematological malignancies.

ACORAI develops a save sensor system to enable cardiac insight by combining Seismic, Acoustic, Visual, and Electrical sensors the Acorai Heart Monitor brings new rich data to healthcare. Cardiac insights are captured in real-time by Acorai’s machine learning engine which has been trained on one of the largest clinical datasets of its kind. A handheld format with an intuitive interface will integrate easily into daily practice.

Epignostix drives molecular tumour classification based on DNA methylation profiling and machine learning.

KUPANDO is a pioneering Berlin-based biopharmaceutical company developing TLR 4/7 agonists that stimulate innate immunityto provide, not only a safe but also affordable, immunotherapy to cancer patients, and to develop immunostimulatory agents with the means to prevent infectious diseases.

Breaking efficacy ceilings in inflammatory and autoimmune diseases.

CereGate is a Brain-Machine Interface company establishing new ways of communication.

Digital health services, insurers, and care providers all over Europe use Thryve’s wearable API to raise interaction and therapy results with a simple access to users’ continuous health data.

An all-in-one surgical system that makes minimally-invasive procedures more efficient.

Transplantation without rejection - a lifelong solutionAllogenetics creates an immunological invisibility of the donor organ instead of inducing immunological blindness in the organ recipient.